Literature DB >> 6321663

Kinetics of [3H]Ro 15-1788 binding to membrane-bound rat brain benzodiazepine receptors.

C L Brown, I L Martin.   

Abstract

Ro 15-1788 is thought to interact specifically with the benzodiazepine receptor population in the mammalian CNS as an antagonist. We have compared the kinetics of interaction of this ligand with the benzodiazepine agonist flunitrazepam in the rat cerebellum. The association of [3H]Ro 15-1788 with the benzodiazepine receptor in this brain region is monoexponential, and the dissociation, initiated either by dilution or by displacement with a number of different ligands, also obeys simple monoexponential kinetics. There is no evidence of cooperative interactions with this ligand, and its dissociation is unaffected by the presence of 100 microM gamma-aminobutyric acid and/or 150 mM sodium chloride. In contrast, the dissociation of the agonist [3H]flunitrazepam is biphasic, and the possible interpretation of this data in terms of agonist-induced conformational change is discussed. Evidence is also presented that the mechanism of interaction of Ro 15-1788 with the benzodiazepine receptor population in hippocampal membranes is distinct from that found in the cerebellum.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321663     DOI: 10.1111/j.1471-4159.1984.tb12691.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  3 in total

Review 1.  Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788.

Authors:  S E File; S Pellow
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  The affinities, potencies and efficacies of some benzodiazepine-receptor agonists, antagonists and inverse-agonists at rat hippocampal GABAA-receptors.

Authors:  J A Kemp; G R Marshall; E H Wong; G N Woodruff
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

3.  Plasma pharmacokinetics and metabolism of the benzodiazepine antagonist [11C] Ro 15-1788 (flumazenil) in baboon and human during positron emission tomography studies.

Authors:  D Debruyne; P Abadie; L Barre; F Albessard; M Moulin; E Zarifian; J C Baron
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Apr-Jun       Impact factor: 2.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.